From digital strategy to clinical reality – the first year of AI in daily pathology practice
Friday, November 27, 2026 at 1:00 pm EET | 12:00 pm CET | 6:00 am EST

Digital pathology is rapidly shifting from pilot projects to high-volume, AI-driven routine clinical practice.
Join Docent Jatta Saarenheimo, PhD (Clinical Cell Biologist, Fimlab Laboratories Oy) and Mikael Jääskeläinen (Key Account Executive, Aiforia) for a practical look inside Fimlab’s first year of live AI deployment in routine breast cancer diagnostics with Aiforia® Breast Cancer Suite.
Discover how Fimlab successfully built a scalable digital infrastructure and integrated Aiforia’s AI solutions into their daily breast cancer diagnostics workflow. You will get a practical look at their learnings and experience in using AI in a digital pathology workflow, real-world operational impact, and the measurable clinical benefits achieved during their first year of live AI deployment.
In this session, you will...
- Learn how Fimlab established an AI-driven digital workflow, focusing on long-term scalability rather than standalone point tools.
- Step inside the routine breast cancer diagnostic pipeline at Fimlab – from AI pre-screening and case prioritization to results review, and streamlined reporting.
- Discover real-world data on turnaround time improvements and cost savings, including faster, more accurate HER2 IHC interpretation, receptor assessments, and a reduction in confirmatory HER2 ISH tests.
- Hear Fimlab's upcoming initiatives, including automated additional orders for breast biopsies and further streamlining routine diagnostic workflows.
➡️ Register for the webinar by filling out the form.
If you cannot attend live, don’t worry—we will send you the recording after the session.
Speakers
Jatta Saarenheimo Docent, PhD, Clinical cell biologist from Fimlab Laboratories Oy
Jatta Saarenheimo is a Clinical Cell Biologist at Fimlab Laboratories in Finland with expertise in molecular and digital pathology. Her work focuses on the implementation of new technologies in pathology, including the integration of AI-based tools into routine diagnostic workflows and their practical adoption in a clinical laboratory environment.
Mikael Jääskeläinen Key Account Executive (Nordics), Aiforia Technologies